Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-12 09:04 am Purchase | 2025-06-30 | 13G | Wave Life Sciences Ltd. WVE | Adage Capital Management, L.P. | 15,016,500 9.650% | 2,500,000![]() (+19.97%) | Filing History |
| 2025-08-12 09:04 am Sale | 2025-06-30 | 13G | Seadrill Limited SDRL | Adage Capital Management, L.P. | 3,138,286 5.040% | -1,062,249![]() (-25.29%) | Filing History |
| 2025-08-12 09:04 am Purchase | 2025-06-30 | 13G | Cabaletta Bio, Inc. CABA | Adage Capital Management, L.P. | 9,002,580 9.990% | 5,368,105![]() (+147.70%) | Filing History |
| 2025-08-12 09:03 am Sale | 2025-06-30 | 13G | ProQR Therapeutics N.V. PRQR | Adage Capital Management, L.P. | 6,601,938 6.270% | -1,500,160![]() (-18.52%) | Filing History |
| 2025-08-12 09:03 am Unchanged | 2025-06-30 | 13G | Ensysce Biosciences, Inc. ENSC | Adage Capital Management, L.P. | 74,711 3.150% | 0 (Unchanged) | Filing History |
| 2025-08-12 09:02 am Purchase | 2025-06-30 | 13G | Cidara Therapeutics, Inc. CDTX | Adage Capital Management, L.P. | 1,100,000 4.970% | 110,000![]() (+11.11%) | Filing History |
| 2025-08-12 09:02 am Unchanged | 2025-06-30 | 13G | Inozyme Pharma, Inc. INZY | Adage Capital Management, L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-08-12 09:02 am Unchanged | 2025-06-30 | 13G | Zeo Energy Corp. ZEO | Adage Capital Management, L.P. | 760,000 3.220% | 0 (Unchanged) | Filing History |
| 2025-08-12 09:02 am Purchase | 2025-06-30 | 13G | Praxis Precision Medicines, Inc. PRAX | Adage Capital Management, L.P. | 1,974,585 9.690% | 231,827![]() (+13.30%) | Filing History |
| 2025-08-12 09:01 am Purchase | 2025-06-30 | 13G | Centessa Pharmaceuticals plc CNTA | Adage Capital Management, L.P. | 8,403,000 6.290% | 1,449,000![]() (+20.84%) | Filing History |
| 2025-08-12 09:01 am Purchase | 2025-06-30 | 13G | Fulcrum Therapeutics, Inc. FULC | Adage Capital Management, L.P. | 4,589,000 8.500% | 1,589,000![]() (+52.97%) | Filing History |
| 2025-08-12 09:00 am Sale | 2025-06-30 | 13G | Aligos Therapeutics, Inc. ALGS | Adage Capital Management, L.P. | 210,000 3.900% | -115,000![]() (-35.38%) | Filing History |
| 2025-06-20 4:05 pm Purchase | 2025-06-20 | 13D | Crescent Biopharma, Inc. CBIO | Adage Capital Management, L.P. | 50,912 0.370% | 50,912![]() (New Position) | Filing History |
| 2025-05-12 09:08 am Purchase | 2025-03-31 | 13G | Seadrill Limited SDRL | Adage Capital Management, L.P. | 4,200,535 6.760% | 771,366![]() (+22.49%) | Filing History |
| 2025-05-12 09:07 am Sale | 2025-03-31 | 13G | Aclaris Therapeutics, Inc. ACRS | Adage Capital Management, L.P. | 8,201,344 7.600% | -1,425,960![]() (-14.81%) | Filing History |
| 2025-05-12 09:07 am Sale | 2025-03-31 | 13G | ProQR Therapeutics N.V. PRQR | Adage Capital Management, L.P. | 8,102,098 7.700% | -1,500,182![]() (-15.62%) | Filing History |
| 2025-05-12 09:06 am Purchase | 2025-03-31 | 13G | Wave Life Sciences Ltd. WVE | Adage Capital Management, L.P. | 12,516,500 8.150% | 12,516,500![]() (New Position) | Filing History |
| 2025-05-12 09:06 am Purchase | 2025-03-31 | 13G | Soleno Therapeutics, Inc. SLNO | Adage Capital Management, L.P. | 4,392,696 9.580% | 1,070,550![]() (+32.22%) | Filing History |
| 2025-05-12 09:05 am Purchase | 2025-03-31 | 13G | Praxis Precision Medicines, Inc. PRAX | Adage Capital Management, L.P. | 1,742,758 8.640% | 888,675![]() (+104.05%) | Filing History |
| 2025-05-12 09:05 am Purchase | 2025-03-31 | 13G | Amylyx Pharmaceuticals, Inc. AMLX | Adage Capital Management, L.P. | 5,697,605 6.430% | 5,697,605![]() (New Position) | Filing History |

